CovidResearchTrials by Shray Alag

CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)

Auto-questionnaires (patients co infected HIV Sras-CoV-2)Wiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (3)

Name (Synonyms) Correlation
drug258 Dexamethasone Wiki 1.00
drug666 Qualitative interviews (in 40 patients : 20 with COVID-19 and 20 without COVID-19) Wiki 1.00
drug119 Biological collection (patients co infected HIV Sras-CoV-2) Wiki 1.00

Correlated MeSH Terms (6)

Name (Synonyms) Correlation
D011024 Pneumonia, Viral NIH 0.17
D055371 Acute Lung Injury NIH 0.16
D012127 Respiratory Distress Syndrome, Newborn NIH 0.15
D012128 Respiratory Distress Syndrome, Adult NIH 0.13
D045169 Severe Acute Respiratory Syndrome NIH 0.07
D018352 Coronavirus Infections NIH 0.06

Correlated HPO Terms (0)

Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials

1 Clinical Characterisation Protocol for COVID-19 in People Living With HIV

There is very little data so far to determine whether people living with HIV (PLWHIV) are at greater risk of COVID-19 acquisition or severe disease. HIV infection is associated with deficiencies in both humoral and cell-mediated immunity that could potentially alter the course and severity of common infections. The investigators will study the correlation between clinical and immunovirological data. The singularity of this work is to have an in-depth immunovirological approach linked to the clinical characteristics in COVID-19 HIV co-infected patients. COVIDHIV is the only study to date to offer this combined approach in PLWHIV. This protocol is a historical and prospective cohort study of PLWHIV presenting COVID-19 The primary objectives are to describe the course of COVID-19 disease in patients infected with HIV

NCT04361604 Adult Patients Living With HIV (PLWHIV) With Confirmed Infection With SARS-CoV-2 Since 1st January 2020 Biological: Biological collection (patients co infected HIV Sras-CoV-2) Other: Auto-questionnaires (patients co infected HIV Sras-CoV-2) Other: Qualitative interviews (in 40 patients : 20 with COVID-19 and 20 without COVID-19)

Primary Outcomes

Description: Biological sample collection

Measure: Describe the course of COVID-19 disease in patients infected with HIV,

Time: 6 months

No related HPO nodes (Using clinical trials)